The incidence of inflammatory bowel diseases (IBD)-Crohn's disease (CD) and ulcerative
colitis (UC)-has been increasing on a global scale, and progressively, more …

Abstract Background Surgical management in Ulcerative Colitis (UC) is typically utilised in
medically refractory cases and, therefore, it is a useful marker for efficacy of medical …

Ulcerative colitis (UC) is an idiopathic inflammatory disorder. These guidelines indicate the
preferred approach to the management of adults with UC and represent the official practice …

Precision medicine is part of five focus areas of the Challenges in IBD research document,
which also includes preclinical human IBD mechanisms, environmental triggers, novel …

Inflammatory bowel disease (IBD), historically subdivided into Crohn's disease and
ulcerative colitis, is a very heterogeneous condition. While the tendency in medicine is to try …

Introduction: Anti TNF-α agents have become a significant advance in the management of
ulcerative colitis, proving to induce, with rapid onset, clinical and endoscopic remission …

Inflammatory bowel diseases (IBD) encompass two main entities including ulcerative colitis
and Crohn's disease. Although having a common global pathophysiological mechanism …

The management of inflammatory bowel disease (IBD) has been transformed over the last
two decades by the arrival of tumor necrosis factor (TNF) antagonist agents. Recently …

The industrial internet of things (IIoT) is a key pillar of the intelligent society, integrating
traditional industry with modern information technology to improve production efficiency and …

Background Inflammatory bowel disease (IBD) follows a heterogenous disease course and
predicting a patient's prognosis is challenging. There is a wide burden of illness in IBD and …